Posted in | News | Materials Testing

Carl Zeiss VivaTome Wins R+D100 Award

Carl Zeiss MicroImaging, a leading provider of microscopy solutions, accepted an award from the R&D 100 in the category of Imaging Technologies for their product the VivaTome. The award was presented on November 11, 2010 during the R&D 100 annual ceremony in Orlando, Florida.

The R&D 100 awards recognize the top technology products of the year in subjects ranging from new materials, chemistry breakthroughs, biomedical products, and high-energy physics. Recipients of the awards work in industry, academia, and government.

Carl Zeiss accepted the award in recognition of the live cell imaging system, the VivaTome. This product was co-developed with Aurox Ltd. The VivaTome, which is based on the principle of aperture correlation, incorporates structured illumination microscopy with the speed of a spinning disk. The result is an economic solution for biomedical researchers interested in examining dynamic processes in living cells and organisms.

"Making a complex imaging technology easy to use for live cell observations was our defined focus", says Dr. Matthias Langhorst, product manager at Carl Zeiss MicroImaging. "Receiving the R&D award for the VivaTome show that the intense discussions between Aurox Ltd and Carl Zeiss during the design phase clearly paid off."

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Carl Zeiss Microscopy GmbH. (2019, February 09). Carl Zeiss VivaTome Wins R+D100 Award. AZoM. Retrieved on May 21, 2024 from https://www.azom.com/news.aspx?newsID=27198.

  • MLA

    Carl Zeiss Microscopy GmbH. "Carl Zeiss VivaTome Wins R+D100 Award". AZoM. 21 May 2024. <https://www.azom.com/news.aspx?newsID=27198>.

  • Chicago

    Carl Zeiss Microscopy GmbH. "Carl Zeiss VivaTome Wins R+D100 Award". AZoM. https://www.azom.com/news.aspx?newsID=27198. (accessed May 21, 2024).

  • Harvard

    Carl Zeiss Microscopy GmbH. 2019. Carl Zeiss VivaTome Wins R+D100 Award. AZoM, viewed 21 May 2024, https://www.azom.com/news.aspx?newsID=27198.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.